---
$id: https://graph.org.ai/products/commodity/51111770
$type: Product
source: UNSPSC
code: "51111770"
title: "Vinfosiltine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinfosiltine

**UNSPSC Code**: 51111770
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C51H72N5O10P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AW1UYE6Q9I, chemically known as vincaleukoblastine, o4-deacetyl-3-de(methoxycarbonyl)-3-((((1s)-1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)- but generally known as vinfosiltine, which bears US NIH Compound Identifier 3086608. European Medicines Agency schedules Vinfosiltine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00065MIG. The term VINFOSILTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). VINFOSILTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinfosiltine under HS 29399900 and SITC 54149. As of Q4 2014, VINFOSILTINE remains the US FDA Preferred Term for this commodity. Vinfosiltine bears US NLM identifiers UMLS ID C0084429 and NCI Concept Code C2378. SMILES: P(=O)(OCC)(OCC)C(NC(=O)C1(O)C2N(C3C(C42C2N(CC4)CC=CC2(C1O)CC)CC(C(OC)C3)C1(CC2CC(O)(CN(C2)CCC2C1[NH]C1C2CCCC1)CC)C(=O)OC)C)C(C)C.

